Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down
Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates
Nevro: Q4 Earnings Snapshot
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth
Nevro (NVRO) Expected to Beat Earnings Estimates: Should You Buy?
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?
Globus Medical strengthens SCS market position with $250m Nevro deal
Piper Sandler Upgrades Nevro (NVRO)
Nevro (NVRO) Upgraded to Buy: What Does It Mean for the Stock?
Globus Medical to acquire Nevro for $5.85 per share
Nevro (NVRO) Soars 13.9%: Is Further Upside Left in the Stock?
Globus Medical to Acquire Nevro in $250 Million Deal to Expand Chronic Pain Treatment Portfolio
Globus to buy Nevro for $250M
Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients
Here's Why you Should Add Nevro Stock to Your Portfolio Now
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
Nevro Stock Falls Despite Q4 Sales Beat on Strong SCS Demand
What Makes Nevro (NVRO) a New Buy Stock
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.